Abstract: The present invention is in the field of processes for the production of nanoparticles. It relates to a process for the preparation of nanoparticles comprising heating a water-free solution containing (a) a metal-organic compound containing an alkaline earth metal and a group 4 metal, and (b) a stabilizer to at least 150° C. for at least 30 minutes.

Abstract: A method and system for enabling a plurality of adaptive streaming client devices to share network resources includes a network node monitoring chunk request messages of client devices configured to select a quality level of a chunk from a plurality of quality levels and to request a media server for transmission of a chunk of the selected quality level. The quality level in a monitored chunk request message of a client device is used to estimate local quality information associated with the quality performance of the client device. Global quality information, determined based on the estimated local quality information associated with the client devices, and being indicative of the global quality performance of the client devices, is sent to the client devices.

Abstract: Disclosed is a filter for selective transmission of visible rays and infrared rays using an electrical signal. The filter comprises: a first filter for controlling the degree of absorption of visible rays by changing the molecular arrangement in accordance with the control of the electrical signal; and a second filter for controlling the degree of reflection of infrared rays by changing reflectivity in accordance with the control of the electrical signal.

Abstract: The present invention provides a scoring system to monitor natural or drug-modified disease progression in erosive inter-phalangeal finger joint osteoarthrits and the use of said scoring system to identify and value drugs with anticatabolic and/or repair promoting potential.

Abstract: The invention relates to a method for preparation of ruthenium-based carbene catalysts with chelating alkylidene ligands (so-called “Hoveyda-type catalysts”) in a cross metathesis reaction by reacting a ruthenium-alkylidene complex with an olefin derivate in the presence of a polymer-supported cation-exchange resin (PSR) acting as a ligand (i.e. phosphine or amine) scavenger. Preferably, penta-coordinated ruthenium benzylidene or indenylidene carbene complexes are employed. The polymer-supported cation-exchange resin (PSR) may be an acidic resin (comprising sulfonic acid or carboxylic groups) or a resin containing carboxylic acid chloride (—COCl) groups or sulfonyl chloride (—SO2Cl) groups. The process is versatile and environmentally friendly; high yields are obtained.

Abstract: A method for correcting a relaxation map of an object scanned with a magnetic resonance imaging modality the object having a plurality of structure and/or tissue types. The method includes deriving a first relaxation map of a scanned object from at least two three-dimensional scans of the object acquired using a sequence of ultrashort echo time pulses adapted for distinguishing between the various types of a plurality of structure and/or tissue types of the object. Information is obtained on the type of structure and/or tissue type present in voxels in the first relaxation map and binarizing the obtained information. A corrected relaxation map is generated by combining the binarized information with the first relaxation map.

Abstract: The present invention relates to blood group A/B/H determinant on Type 1 Core glycosphingolipids chains as recognition point for the FedF protein of F18-fimbriated Enterotoxigenic and verotoxinogenic Escherichia coli and the use of compounds comprising such determinants for the treatment of F18? E. coli infections in pigs and in screening methods.

Abstract: The present invention provides a scoring system to monitor natural or drug-modified disease progression in erosive inter-phalangeal finger joint osteoarthrits and the use of said scoring system to identify and value drugs with anticatabolic and/or repair promoting potential.

Abstract: A compound of formula (I) for use as an adjuvant in vaccination; wherein R is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 50 carbon atoms; R1 is an optionally-substituted alkyl, alkenyl, alkynyl, aryl, arylalkyl or alkylaryl moiety having from 1 to 40 carbon atoms; each of R2, R3 and R4 is independently selected from an optionally-substituted alkylene, alkenylene, alkynylene, arylene, arylalkylene or alkylarylene moiety having from 1 to 40 carbon atoms; each of X, Y and Z is independently selected from an optionally-substituted alkylene, alkenylene, alkynylene, arylene, alkylarylene or cycloalkylene, ketone, ester, amide, imide, imine, thioether, ether, thioester, thioketone; and P is selected from hydrogen, an alkyl group, a sugar residue, or a metal, phosphonium or ammonium species; wherein at least one of X, Y and Z includes a moiety selected from cyclopropyl, C=A, C-AH and C—OR5; wherein R5 is alkyl or haloalkyl, and A is S, O or NR6, wherein R6

Abstract: The invention relates generally to the field of virology. More particularly, the present invention relates to methods for determining the permissiveness of a cell for a virus that is a member of the family Arteriviridae or Coronaviridae or Asfarviridae, in particular for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). The invention further provides methods and compositions related to the generation of host cells permissive for a virus that is a member of the family Arteriviridae or Coronaviridae or Asfarviridae, in particular for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Methods of using said cells thus identified or thus generated, in preparing a culture of a virus that is a member of the family Arteriviridae or Coronaviridae or Asfarviridae, as well as the use of said virus for the purpose of vaccine production or diagnosis, are also provide by the present invention.

Abstract: Methods of treating a glucocorticoid-responsive condition in a subject are provided according to embodiments of the present invention which include administering, in combination, a glucocorticoid receptor agonist and a PPAR agonist in therapeutically effective amounts. It is an aspect of the present invention that the amount of the glucocorticoid receptor agonist used in a method of treating a glucocorticoid-responsive condition is less than an amount of the glucocorticoid receptor agonist necessary to achieve a therapeutic effect if administered in the absence of the PPAR agonist.

Abstract: A method for performing end-to-end vessel anastomosis includes providing a vessel support including a vessel receiving portion and a handle portion extending therefrom. The vessel receiving portion is an annulus. The vessel receiving portion is positioned around the end of a first vessel and the end of the first vessel is everted about the outer diameter of the vessel receiving portion such that the inner surface of the vessel is directed outwardly. The end of the second vessel is positioned over the everted end of the first vessel such that the inner surface of the second vessel is disposed against the inner surface of the first vessel. A surgical adhesive is provided and is used to adhere the ends of the vessels together without requiring the application of heat or radiant energy. The handle portion of the vessel support may be removed.

Abstract: The invention relates to a pressure probe for characterizing the pressure and/or differential pressure in a fluid, and all derivatives, like for instance, flow rate. The device comprises a front side adapted for facing an upstream direction of the fluid flow, a bulbous part adapted for creating a region of low pressure, also called wake, and a flow detachment means. The front side allows creation of a region of high pressure. It has a planar shape or the shape of a recess. The device thus allows to be substantially flow angle independent, to be Reynolds number independent in a wide range of flow velocities and to obtain a large differential pressure gain.